Abstract: An elevated optic nerve head can be an ominous sign, sometimes signifying an underlying basis for raised intracranial pressure. Alternatively, patients may harbor a different mechanism for this optic nerve head appearance, including optic disc drusen (ODD), which does not confer any life-threatening implications. It is important to refine the approach to distinguishing ODD from papilledema because this is a relatively common, and important, conundrum encountered in clinical practice. Optical coherence tomography (OCT) is a noninvasive, readily accessible, and cost-effective ocular imaging technique that can improve the diagnostic accuracy for detecting ODD; or, instead, increase the index of suspicion for papilledema, thus prompting additional investigations needed to identify (or exclude) potential causes of raised intracranial pressure. In this review, we will discuss the value of OCT in the diagnostic approach to cases of mild optic disc elevation, with acknowledgment of the potential pearls and pitfalls of this imaging technology. In particular, we will emphasize the helpful role OCT can play in differentiating cases of ODD from mild papilledema in the context of idiopathic intracranial hypertension (IIH).
owing to differentiating features with respect to the clinical presentation and fundus examination. For example, a diabetic patient who awakens with sudden awareness of painless altitudinal vision loss and optic disc edema would not typically be mistaken as having ODD (in isolation) as the basis of vision loss, in the authors' collective clinical experience, unless he or she happened to harbor both diagnoses. Moreover, severe papilledema is generally a readily identifiable diagnosis, based on the funduscopic findings alone, and should not be confused with ODD for this reason.
Yet, these case scenarios are somewhat polarizing on the diagnostic spectrum, and the reality of clinical practice is often more nuanced. Specifically, health care specialists are challenged to elucidate the etiology of optic disc elevation, when the manifestations are relatively mild. In this context, the differential includes low-grade papilledema versus buried ODD as a cause of pseudopapilledema ( Fig. 1) . 1, 2 These diagnoses may be particularly difficult to differentiate if the patient reports no systemic or neurologic complaints. 1, 2 Arguably, one approach would be to investigate each and every case of optic disc elevation with the full arsenal of tests needed to exclude raised intracranial pressure, 2 including cranial magnetic resonance imaging with venography and lumbar puncture. 1, 2 Although seemingly effective, this method is not optimal for all patients. The aforementioned investigations are both costly and invasive and should be performed with a reasonable pretest probability of identifying the posited mechanism of raised intracranial pressure. Fortunately, advances in OCT have shown that this noninvasive ocular imaging technique may represent a new putative "gold standard" for diagnosing cases of buried ODD. 2 Furthermore, the use of OCT may obviate the need for invasive investigations, at least for some patients presenting with mild optic disc elevation. 2 In this review, we emphasize the role of specific OCT measures that can be used to differentiate ODD from mild papilledema associated with idiopathic intracranial hypertension (IIH) as a cause of mild optic disc elevation (Table 1) . decreased in the setting of postpapilledema optic atrophy. Automated software segmentation of the retinal layers using a 3D graph-based approach has improved the accuracy of defining the thickness of the retinal layers in papilledema.
The macular GCIP may show low GCIP thickness in cases of papilledema due to software algorithm failures. OCT algorithms that take advantage of 3D information in lieu of 2D information from single B-scans may help overcome this problem. In chronic papilledema GCIP thinning may represent damage to retinal ganglion cells and optic nerve injury.
The shape characteristics of the Bruch membrane with angling toward the vitreous can be present in papilledema. This angle can also vary to some degree within normal eyes without papilledema. Moreover, absent angling does not exclude papilledema.
The scleral canal size is enlarged in eyes with mild papilledema and narrows as the papilledema resolves. Optical coherence tomography has been used to detect and characterize choroidal wrinkles and folds, which accompany papilledema in a significant proportion of cases.
With improved penetration of EDI-OCT, more reliable means of using the Bruch membrane angling in diagnosing papilledema and tracking response to therapy may be identified.
Older OCT studies have shown a smooth internal edge and lazy V pattern of the SHYPS in papilledema. PHOMS represents herniated, distended axons due to optic nerve head congestion and is seen in a significant number of papilledema cases. Hyperreflective bands are not seen in eyes with papilledema.
Using EDI-OCT, the visualization of lamina cribrosa sometimes mimics hyperreflective bands found in eyes with ODD. However, in this case they are restricted to a very deep anatomical location in the optic nerve head.
ODD
In initial stages, it is common to find an increase of peripapillary RNFL thickness by OCT, but as drusen continue to develop, the RNFL thickness decreases.
The macular GCIP analysis may show thinning earlier than the RNFL thickness in buried ODD due to retinal ganglion cell damage and optic nerve injury.
The Bruch membrane angling has not been used to identify ODD.
The scleral canal size has been found to be smaller in children with ODD compared with healthy controls.
Not applicable With EDI-OCT, ODD can be directly visualized and appear as regions of low reflectivity bordered by hyperreflective margins.
Older OCT studies have shown a lumpy-bumpy internal contour of the SHYPS in ODD. PHOMS represents herniated, distended axons due to optic nerve head congestion and is seen in a significant number of ODD cases. Hyperreflective bands are often seen in eyes with ODD. In cases of unilateral ODD, the bands will also likely be found in the eye without ODD.
Key Points
RNFL thickness can be variably increased or decreased in ODD and IIH and cannot be relied upon to distinguish these diagnoses. Macular GCIP measures may be normal or decreased in both ODD and papilledema and cannot be relied upon to distinguish these diagnoses.
Currently the angling of the Bruch membrane has not been validated as a means of differentiating papilledema from ODD.
Scleral canal size might work as a tool to differentiate ODD from papilledema but it has not been validated in any studies and it is challenged by a huge variation of scleral canal size in the general population.
The presence of choroidal wrinkles and folds can help identify cases of papilledema.
By using EDI-OCT to directly identify ODD, it is possible to distinguish these cases, except in circumstances where the 2 diagnoses coexist.
The SHYPS thickness is an epiphenomenon of poor penetration achieved with older OCT technology and cannot be used to discriminate papilledema and ODD.
PHOMS is a nonspecific marker of axonal congestion and cannot be used to discriminate papilledema and ODD.
The finding of hyperreflective bands in different depths of the prelaminar
OPTICAL COHERENCE TOMOGRAPHY: INTERPRETING THE FINDINGS
Since the invention of the ophthalmoscope, an edematous optic disc appearance has been visualized as an acute manifestation of optic nerve injury, caused by a myriad of potential mechanisms, including ODD, demyelination, ischemia, infiltration, and raised intracranial pressure. Despite the obvious value of ophthalmoscopy in the clinical setting, this technique is limited by the qualitative nature of the evaluation. Simply stated, many different causes of mild optic disc elevation can look the same.
Optical coherence tomography is an ocular imaging technology that uses principles of low-coherence interferometry to acquire high-resolution (within 3-7 μm), noninvasive cross sectional information from anatomical structures in the eye in vivo. 2 Changes in retinal structure that reflect optic disc edema versus optic atrophy may be followed longitudinally with OCT. Recent developments with swept source OCT imaging have enabled the collection of OCT scans with less than 30 μm between each B-scan, which has facilitated easy visualization of small structures in the optic nerve head such as ODD. 2, 3 The longer wavelengths of swept source OCT are excellent in penetrating deeper retinal structures, albeit with some sacrifice of axial resolution. 2, 3 Enhanced depth imaging (EDI) OCT has its highest sensitivity near the inner sclera, which means the structure, size, and shape of lesions such as buried ODD may be easily characterized. [1] [2] [3] OCT: Measures of Interest in Differentiating ODD from Papilledema
Peripapillary Retinal Nerve Fiber Layer Thickness
The retinal nerve fiber layer (RNFL) harbors the axons of the retinal ganglion cells and is a unique central nervous system (CNS) structure because it lacks myelin. Changes in RNFL thickness, as measured by OCT, are therefore interpreted to reflect axonal damage or dysfunction. 4 Thickening of the RNFL can be observed in cases of optic nerve swelling due to a variety of pathologies, including optic neuritis, papilledema, and AION. 1 In patients with CNS inflammatory syndromes such as multiple sclerosis or neuromyelitis optica spectrum disorder, reduced RNFL values are interpreted to represent axonal damage, which can arise from retrograde axonal degeneration from inflammatory lesions in the optic nerve, chiasm, tracts, and radiations. 4 Similarly, RNFL thinning can occur with postpapilledema optic neuropathy or optic nerve injury caused by ODD. The pattern of RNFL injury observed in cases of an elevated optic nerve head appearance can enhance our understanding regarding optic nerve pathology, in the context of a well-elucidated history.
When interpreting OCT-measured RNFL changes, it is important to acknowledge the limitation of the so-called "floor effect," which means that with standard commercially available OCT machines, RNFL values do not decrease below 30 μm regardless of the extent of optic nerve injury because nonneural elements in the retina contribute to the remaining thickness. 5 For practical purposes this makes OCT-measured RNFL changes less useful in trying to detect new axonal injury, superimposed on severe optic nerve damage. Another well-established challenge with conventional OCT machines is segmentation algorithm errors that lead to inaccurate RNFL measurements in cases of moderate to severe papilledema. 6 
Ganglion Cell/Inner Plexiform Layer Thickness
Current spectral domain (SD)-OCT machines often provide a composite measure of ganglion cell layer and inner plexiform layer thickness. 4 Thinning of ganglion cell/inner plexiform layer (GCIP) in the setting of an optic nerve injury is interpreted to represent neuronal loss. 4 For some OCT machines, transient decreases in GCIP thickness have been observed in the setting of optic disc edema due to software algorithm failures, and caution should be applied when interpreting this loss as early neuronal injury. 6 It is possible that, with advancing OCT techniques, GCIP thinning may emerge as an early means of identifying optic nerve injury in ODD and papilledema.
EDI-OCT
In 2008, EDI-OCT was first reported by Spaide et al 7 to address the limitations of conventional SD-OCT for imaging deep ocular structures. The method initially described involved positioning the OCT apparatus close enough to the eye to create an inverted view of the fundus. 3, 7 As a result, the coherence gate was placed at a deeper plane than its usual position in the vitreous, which moved the position of peak sensitivity from near the posterior vitreous in conventional OCT to the inner sclera for EDI-OCT. 3, 7 Using this technique, it is possible to visualize structures 500-800 μm deeper than with conventional OCT, thus providing better views of ODD structure, size, and shape. 2, 3 In a recent report EDI-OCT has been shown to be more sensitive to the detection of ODD than B-scan ultrasound, which has previously been regarded as "gold standard" for this diagnosis. 
Bruch Membrane Morphology
Studies have shown that the effects of elevated intracranial pressure may deform optic nerve head structures, particularly the peripapillary Bruch membrane and retinal pigment epithelium. Kupersmith and colleagues 8 used OCT to compare optic nerve and peripapillary RNFL findings among patients with papilledema, optic neuritis, and nonarteritic AION. As part of their study protocol, they measured the angle of the retinal pigment epithelium-Bruch membrane at the temporal and nasal borders of the neural canal opening. 8 A positive angle was noted when there was inward deflection of these structures, with angulation toward the vitreous, whereas a negative angle was associated with outward angulation. 8 Among 30 eyes with papilledema, 20 eyes (67%) had positive angles, compared with 1 in 8 optic neuritis eyes and 1 in 12 nonarteritic AION eyes. The results of this study suggested that OCT-captured morphological changes in the Bruch membrane may be used to differentiate papilledema from other cases of optic disc elevation.
OCT IN THE DIAGNOSIS AND MANAGEMENT OF IIH Idiopathic Intracranial Hypertension: A Brief Overview
Typically, IIH is a condition that affects young women during their reproductive years. 9, 10 Although the cause of IIH is unknown, its clinical expression is associated with increased body mass index. 9, 10 Common symptoms of IIH include headaches, transient visual obscurations, pulsatile tinnitus, and back and neck pain.
Optical coherence tomography can also aid the diagnosis and the management of IIH, although its utility is highly context-dependent. In the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT), SD-OCT was used to assess treatment efficacy of acetazolamide plus weight management, versus placebo with weight management, in the eyes of IIH patients with mild visual loss. 13 In this study, RNFL thickness, total retinal thickness, optic nerve volume, and GCIP measurements were derived using 3-dimensional (3D) segmentation techniques. 13 At study entry, OCT values were comparable between both groups. After 6 months, the treatment group had greater reduction than the placebo group with respect to RNFL values (175 μm versus 89 μm, P = 0.001), total retinal thickness (220 μm versus 113 μm, P = 0.001), and optic nerve head volume (4.9 mm 3 versus 2.1 mm 3 , P = 0.001). 13 Hence, the IIHTT experience suggests that OCT could serve a role in monitoring longitudinal response to therapy in IIH patients, in concert with rigorous ophthalmic assessment and reliable measures of optic nerve function.
From a diagnostic perspective, OCT is not needed to identify moderate to severe cases of papilledema because this clinical finding is often evident on fundus examination. To confound matters, patients with severe papilledema manifest elevations in RNFL thickness that cannot be reliably quantified by OCT due to software algorithm failures. 6 In a recent study by Aojula and colleagues, 14 OCT segmentation errors were compared between 52 IIH patients versus control subjects. Scans obtained from 6 IIH patients in this study were excluded because the extent of their papilledema caused truncation of the scan images and the extent of RNFL thickening could not be visualized.
14 Among the remaining 46 IIH subjects, there were more segmentation errors noted in RNFL thickness relative to controls, and these errors were particularly prominent in cases of moderate to severe optic disc swelling.
14 Thus, segmentation errors can stymy efforts to follow papilledema in IIH patients longitudinally with standard SD-OCT machines used in the clinical setting. Recent automated OCT software segmentation of the retinal layers employing 3D graph-based methodology has improved the accuracy of defining the thickness of the retinal layers in the setting of papilledema and is associated with fewer algorithm failures. 6 With this approach, the surface of each retinal layer is determined within the scan volume using all of the surrounding 3D features in the OCT scan and not simply the features in each individual B-scan. 6 Wang et al 15 used 3D segmentation methodology to show that volumetric measurements of optic disc swelling in subjects with papilledema correlated somewhat with Frisén scale grades assessments of papilledema and 2-dimensional (2D) measures of peripapillary RNFL and total retinal thickness. 15 Based on their observations, these investigators suggested that this methodological approach may provide a more continuous, objective, and robust means for assessing the degree of disc swelling in IIH patients with papilledema. 15 In related work, Albrecht and colleagues 16 used SD-OCT to longitudinally analyze retinal and optic nerve head morphology of 21 patients with IIH versus 27 age-and sex-matched healthy controls over time. These investigators also quantified optic nerve head volume and employed semiautomated segmentation of macular volume scans to assess the macular RNFL and GCIP volumes, along with total macular volume. 16 In IIH patients, the optic nerve head volume was increased and correlated with CSF opening pressures. 16 As would be expected, optic nerve head volumes decreased after treatment with acetazolamide. 16 This study served Yet, the clinical presentation of IIH is highly variable, which can contribute to delays in diagnosis. 9, 10 Fundus evaluation in IIH patients typically reveals papilledema of variable severity. The term papilledema refers to swelling of the intraocular, prelaminar portion of the optic nerve head that arises from elevated intracranial pressure, transmitted via the cerebrospinal fluid (CSF) located within the retrobulbar optic nerve sheath. 10 Although frequently bilateral, papilledema may be asymmetric or even unilateral among IIH patients. 10 The optic nerve often appears elevated in cases of papilledema, with associated blurred disc margins and obscuration of major vessels. In some cases, accompanying hemorrhages and cotton wool spots may be observed around the edematous optic nerve. Fundus features that can help identify true papilledema from other causes of optic disc elevation include thickening of the peripapillary RNFL, telangiectatic disc vessels, and obscuration of branch vessels at the optic disc margin. 11 Yet, intraobserver agreement regarding papilledema grade is relatively poor, even among experienced observers when using the noncontinuous Frisén scale. 6 In published reports, IIH has sometimes been referred to as "benign" intracranial hypertension, but this moniker is regrettably misleading because the disorder can lead to substantial visual morbidity if left untreated. 10 Chronic papilledema can cause progressive and permanent loss of nerve fibers within the optic nerve. Both small and large fibers are affected, but more peripheral retinal nerve fibers tend to be affected earlier and to a larger extent. 11 The characteristic visual field defects caused by papilledema, aside from big blind spots, tend to be arcuate in shape and involve the inferior periphery, owing to prominent nerve fiber loss superiorly in the optic nerve. 11 In the absence of secondary complications (AION or retinal vein occlusion), visual acuity is usually preserved until late stages of disease progression in patients with papilledema. Yet, macular abnormalities, including choroidal folds, hemorrhages, localized nerve fiber layer edema, and subretinal fluid (which tends to correlate with the degree of macular thickening), may acutely degrade central visual acuity.
11
The mainstay of management for IIH patients is weight loss and acetazolamide (a carbonic anhydrase inhibitor that reduces CSF production and lowers intraocular pressure). [9] [10] [11] Notably, CSF diversion procedures are indicated in IIH patients with visual loss that progresses in severity, or alternatively is severe on presentation. Commonly employed surgical options used to salvage vision in these situations include optic nerve sheath fenestration and the placement of lumboperitoneal or ventriculoperitoneal shunts.
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OCT: What Is Its Value in the Diagnosis and Management of IIH?
The diagnosis of IIH is rendered for patients who meet the modified Dandy criteria. 12 Investigations include cranial (and orbital) magnetic resonance imaging with venography, which frequently demonstrates an empty sella turcica (present in 70% of IIH patients); distension of the optic nerve sheaths (reported in 45% of IIH patients); segmental narrowing of the transverse sinuses; and flattening of posterior globes (seen in 80% of patients). 10 A lumbar puncture is required for suspected IIH patients, both to determine the opening pressure (normal is up to 25 cm of water in the lateral decubitus position) and confirm that CSF constituents are normal. 10, 12 Elevated CSF cell counts and/or protein levels can implicate an alternate cause of raised intracranial pressure, including meningitis or CNS inflammation.
to demonstrate that OCT can be used to noninvasively monitor changes in retinal and optic nerve head morphology in patients with IIH. Increased optic nerve head volume was found to be associated with retinal atrophy (defined by OCT-measured macular RNFL volume loss), presumably due to "mechanic jamming" of the optic nerve at the disc and subsequent axonal loss. 16 Another proposed application of OCT to facilitate the diagnosis and follow-up of papilledema is measuring deformations in the angling of the Bruch membrane (Fig. 2) . 6, 8, 17, 18 Sibony and colleagues 17 used OCT to evaluate patients with papilledema before and after lumbar puncture, CSF shunt, and medical treatment. The anterior deformation of the peripapillary retinal pigment epithelium-Bruch membrane layer became more "V-shaped" after each CSF pressure-lowering intervention for raised intracranial pressure. 17 These shape changes were also noted to occur in patients with ongoing intracranial pressure elevation who manifested secondary optic atrophy. 17 From these findings, the investigators concluded that OCT-measured changes in Bruch membrane angling, in concert with RNFL thickness, could be used to monitor effects of raised intracranial pressure and may be especially helpful in gauging treatments in patients with secondary optic atrophy. 17 Gampa et al 18 used the OCT techniques described by Sibony to perform pre-and postlumbar puncture evaluations of peripapillary Bruch membrane shape parameters with OCT. Changes in peripapillary Bruch membrane shape were detected within 1 hour of intracranial pressure-lowering procedures, suggesting that this OCT finding may be a useful measure of the effectiveness of intracranial pressure-lowering procedures in some patients. 18 Yet, caution needs to be applied when interpreting qualitative changes in Bruch membrane morphology, as some investigators have failed to observe these OCT findings in patients with proven papilledema. 19 It is also noteworthy that Bruch membrane angle can vary in normal individuals. More specifically, slightly positive angling toward the vitreous, neutral and horizontal, or negative angling toward the retrobulbar compartment may be observed in the absence of optic nerve pathology. 6 As OCT technology continues to advance, it is possible that improvements in depth penetration and longer wavelength light may help reconcile the role of morphological changes in the Bruch membrane, in the diagnosis and management of IIH. 6 Optical coherence tomography has been used to detect and characterize choroidal wrinkles and folds, which accompany papilledema in some IIH patients. 20 Sibony and colleagues 20 identified 3 types of folds in IIH patients, including peripapillary wrinkles, retinal folds, and choridal folds with greater sensitivity using OCT than relying on fundus photos alone (41% of patients have wrinkles or folds with photos, whereas 73% have them with OCT) (Fig. 2) . Thus, the improved sensitivity in detecting choroidal changes could help differentiate papilledema in IIH patients, from cases of pseudopapilledema. Finally, it has been the authors' (unpublished) experience that longitudinal follow-up with OCT offers key diagnostic information in cases of IIH with subtle papilledema that might otherwise be missed. Patients presenting with IIH tend to have variations in their RNFL measures that exceed the 5-6 μm test-retest variability of SD-OCT testing, and at times it is the longitudinal variation that provides the earliest clue to diagnosis in cases of mild papilledema, particularly for patients with normal vision and a paucity of symptoms related to raised intracranial pressure. Another advantage OCT offers in following papilledema is that early evidence of neuronal loss (measured as GCIP thinning) can provide evidence of ongoing optic nerve injury, when the RNFL values are decreasing in ominous fashion due to neuroaxonal injury, in lieu of reflecting improved disease control. However, commercial algorithms for segmenting the GCIP complex were designed for normal and glaucoma eyes and often fail in the presence of optic disc edema. 6 Therefore, OCT algorithms that incorporate 3D information instead of merely 2D information from single B-scans may ameliorate this problem. 6 The role of OCT-measured GCIP in the follow-up of papilledema will undoubtedly be the focus of future studies and may help define structure-function relationships that influence visual outcomes and facilitate the management of IIH patients.
THE ROLE OF OCT IN DIAGNOSING ODD Optic Disc Drusen: A Brief Overview
Optic disc drusen are acellular bodies of hyaline deposits located in the prelaminar region of the optic nerve head. 2, 21, 22 An ODD prevalence of 2.4% has been found in autopsy studies, though it has been reported to be significantly lower using in-vivo imaging modalities. 21, 23 Patients with ODD may be completely asymptomatic but at times report visual blurring and/or visual field loss. 2, 24 In fact, visual field defects are found in approximately 90% of patients with visible, also referred to as "superficial," A B C ODD. [22] [23] [24] The fundus findings include the appearance of yellowish glistering elements or conglomerates on the optic disc surface. As ODD have been reported to slowly become more visible with age, "superficial" ODD are mainly seen in older patients. [25] [26] [27] [28] Likewise, the visual field defects in ODD patients tend to slowly progress over time. 25, 29, 30 In children with ODD the main finding on ophthalmoscopy is blurring of the optic disc margin and optic disc elevation, as ODD are often located deep in the optic nerve head. Hence, patients with "buried" ODD can have a similar optic disc appearance to IIH patients with mild papilledema (Fig.  1) . Previously, ODD have been diagnosed using ophthalmoscopy, B-scan ultrasound, fundus autofluorescence, computerized tomography, and fluorescein angiography.
2,3 B-scan ultrasound was previously viewed as the most reliable means to diagnose ODD, but as this imaging method is insensitive to uncalcified ODD and has low resolution, recent studies suggest OCT is the new putative "gold standard" in diagnosing ODD.
1,2,31
ODD: The Role of OCT in Diagnosis and Management
The choice of OCT acquisition protocol plays a key role when diagnosing ODD. 31 Because ODD in some cases might be only a few microns in size, OCT images with limited sections within the scan area could overlook small ODD. With the introduction of the faster acquisition spectral domain EDI-OCT, the resolution and penetration of the optic nerve head has improved substantially, and it is now possible to perform dense optic nerve head scans with less than 30 μm between each section. By using dense optic nerve head scans, smaller ODD are not likely to be missed. When visualized with OCT, ODD are seen as signal-poor structures surrounded by hyperreflective margins (Fig.  3) . 1, [31] [32] [33] [34] [35] Several papers have diagnosed peripapillary hyperreflective ovoid mass-like structures (PHOMS) as representing ODD precursors or variants (Fig. 3) , [36] [37] [38] [39] [40] but recent studies have established that these structures are in fact herniating, distended axons that can be seen in a variety of acquired and dysplastic optic discs. 31, [41] [42] [43] Otherwise stated, PHOMS may be observed in ODD eyes but are by no means unique to this condition. Several other structures may also potentially be mistaken for ODD with OCT imaging. For example, blood vessels imaged cross-sectionally on OCT are also hyporeflective but can be differentiated from ODD as they cause shadowing of the underlying layers. Furthermore, these blood vessels normally demonstrate a figure 8 configuration, 31 also distinguishing them from ODD (Fig. 3) . Enhanced depth imaging OCT has provided better penetrance and in turn made it possible to quantify ODD size, delineate ODD borders, and to assess the integrity of adjacent retinal structures. Traber and colleagues 40 have used EDI-OCT to characterize ODD morphology into 3 types: peripapillary subretinal drusen, granular drusen, and confluent drusen. In this study, large and autofluorescent ODD were more commonly found in patients with visual field loss. 40 Indeed, with the increased resolution of SD-OCT and the deeper penetration of EDI-OCT, it has now become possible to segment ODD and optic nerve head structures, along with quantifying ODD volume and anatomic location. 35, 44 Compared with other imaging modalities used in ODD diagnostics, the ability to quantify volume and anatomic location in the optic nerve head is unique to OCT.
Using OCT to Define Structure-Function Relationships in Patients With ODD
Patients with ODD have historically been monitored for functional deficits using Goldmann or standard automated perimetry techniques. With the introduction of OCT, it has become possible to monitor patients with objective structural measures, including peripapillary RNFL thickness and macular GCIP layer thickness. In ODD eyes, OCT-measured RNFL thickness has been found to correlate with visual field loss, as measured by perimetric mean deviation. 24 Moreover, RNFL values have been shown to decline in follow-up studies of ODD patients, reflecting progressive axonal injury. Skatt and colleagues 45 used EDI-OCT and 3D reconstruction software to assess the relationships among ODD volume, RNFL thickness, and visual field deficits. They noted that larger ODD volumes correlated with reduced RNFL values and worse visual field loss. 45 Similar findings have been reported by Malmqvist et al 44 who used EDI-OCT to determine how quantitatively estimated volume and anatomic location of ODD influence optic nerve function. In this study, anatomic characteristics of ODD were compared with functional outcomes, including automated perimetric mean deviation and multifocal visual evoked potentials. 44 Increased age, larger ODD volume, and more superficial anatomic ODD location were found in patients with ODD visible by ophthalmoscopy as compared with patients with buried ODD. 44 Worsening of visual field function was associated with larger ODD volume, whereas no association was found among visual field function, ODD location, age, and drusen visibility by ophthalmoscopy. 44 Decreased retinal GCIP thickness was significantly associated with worse visual field function, and correlations between GCIP and mean deviation were more robust than those observed for RNFL thickness. 44 Recent publications therefore suggest that OCT may be used to monitor progressive visual function loss in patients with ODD. Moreover, GCIP analysis may represent the most sensitive means of detecting neuronal injury that may underpin functional decline in ODD patients. 44, 46 Yet, though it is currently possible to reconstruct 3D OCT images and segment ODD, the degree of calcification and other unknown factors likely play a role in contributing to optic nerve damage. Consequently, ODD segmentation requires further investigation as a means of monitoring ODD progression and associated vision loss.
DIFFERENTIATING OPTIC DRUSEN FROM PAPILLEDEMA USING OCT
As previously stated, ancillary testing, including OCT, is not generally needed to distinguish visible ODD from moderate to severe forms of papilledema. These diagnoses are readily apparent from the fundus examination alone. In clinical practice, however, it can be very difficult to differentiate buried ODD from mild papilledema (Fig. 1) and to this end, OCT may have utility in refining the approach used to discriminate between the two conditions ( Table 1, Fig. 4 ). With the introduction of OCT, an initial focus for differentiating papilledema from ODD was the RNFL thickness. Several papers have reported increased peripapillary RNFL thickness in IIH patients when compared with ODD patients. 36, [47] [48] [49] Furthermore, optic nerve head elevation, 34 internal contour of the optic nerve head, and subretinal hyporeflective space (SHYPS) in the optic nerve head 36, 47, 50 as measured by OCT have all been reported to significantly distinguish optic disc edema from pseudopapilledema caused by ODD. The main problem with relying on OCT-measured RNFL in this context, however, is that most studies have only evaluated patients with visible ODD. It is well known that these patients have more severe RNFL thinning than patients with buried ODD. 24 In contrast, a study by Kulkarni et al 19 found no difference in RNFL thickness between patients with buried ODD versus mild papilledema secondary to IIH. It is also noteworthy to mention that the use of internal optic nerve head contour and SHYPS in the differentiation between optic disc edema and pseudopapilledema in previous studies was often based on time-domain OCT images. Unfortunately, this prior generation of OCT had relatively low resolution and poor penetration depth, as compared with EDI-OCT. As contemporary OCT imaging methods have improved it has become clear that the so-called hyporeflective space was in fact only hyporeflective due to poor penetration of the optic nerve head layers in patients with optic disc protrusion.
In reviewing the published literature of OCT in ODD, another problem becomes evident. Several studies have misdiagnosed PHOMS as ODD precursors or variants and have thereby potentially compared patients with papilledema with those with other optic neuropathies associated with PHOMS. 36, 38, 39 The misinterpretation of PHOMS as ODD leads to a significant clinical challenge, as patients with vision and life-threatening causes of raised intracranial pressure could be misdiagnosed as having ODD.
Optical coherence tomography measures of scleral canal size, measured as the termination of the Bruch membrane, have gained recent attention as a means of differentiating ODD from papilledema. Specifically, scleral canals have been shown to be smaller in patients with ODD. 51 A recent study by Thompson et al 52 has also shown that the Bruch membrane opening is enlarged in eyes with mild papilledema and narrows as the papilledema resolves. Even though OCT measures of RNFL thickness, GCIP thickness, and the Bruch membrane opening have not been validated as a means of differentiating ODD and papilledema, when used in combination they may provide some discriminatory value, although this awaits further study.
In 2016 Birnbaum and colleagues 53 reported a very high prevalence of ODD at 19% (75 of 392 eyes) in patients with resolved papilledema from IIH. Based on this high value the authors suggested a noncoincidental relationship. In this study, the diagnosis of ODD was made in the setting of visible drusen based on imaging, autofluorescence, B-scan ultrasound, computed tomography scan, or OCT. 53 The authors used various OCT methods but did not employ the EDI option. Instead they relied on the aforementioned abrupt taper of the SHYPS as a sign of ODD. We now know that SHYPS was an artefact of early generations of OCT, as previously described. 2 Furthermore, although some of the patients with resolved papilledema have had ODD as well, it is evident from the paper by Birnbaum et al 53 that PHOMS were erroneously identify as ODD and thereby likely contributed to the unusually high reported prevalence of ODD in patients with resolved papilledema. No studies thus far have been published regarding the prevalence of ODD in patients with current or resolved papilledema using high-quality EDI-OCT scanning protocols. Therefore, there is no convincing data to date to suggest that the prevalence of ODD is higher in IIH patients than in the general population, or that "secondary ODD" is an actual entity.
Finally, early reports evaluating composite multicolor OCT images suggest that certain characteristics, including features of a greenish hyperreflectance that extends beyond the optic disc margins, may be used to distinguish cases of papilledema from pseudopapilledema (with or without ODD). 54, 55 In the future, multicolor techniques may further refine the diagnostic approach used to elucidate causes of an elevated optic disc appearance, but this awaits further study.
CONCLUSIONS
The need to differentiate cases of ODD from mild papilledema remains an important clinical challenge. To this end, OCT adds value to the diagnostic approach, particularly for health care providers who do not regularly perform fundoscopy. The obvious advantage OCT offers in this context is that ODD can be directly visualized with EDI-OCT techniques. Simply put, the most effective way to determine whether an optic nerve head is elevated due to ODD is to diagnose ODD. It is important to reiterate that many of the OCT findings previously described in the published literature (PHOMS, SHYPS, RNFL thickening, and GCIP thinning, to name a few) are nonspecific and can be found in eyes affected by both ODD and papilledema. For this reason, physicians should view OCT as an ancillary test that should be used to complement the history and examination findings determined from a thorough ophthalmic assessment. In a case of optic disc elevation with no evidence of ODD, it may be necessary to perform cranial imaging and CSF analysis, particularly if the patient presents with symptoms of raised intracranial pressure. Even in eyes with established ODD, further investigations may be needed if there is any suspicion whatsoever that the patient may harbor more than one mechanism of optic disc elevation. In summary, as OCT technology continues to advance, so too will our understanding regarding its role in the diagnosis and management of patients with a variety of different optic neuropathies, including ODD and papilledema.
